Physician

Fernando Boccalandro, M.D.

According to 2025 Medicare claims, Fernando Boccalandro, M.D. (NPI: 1467441428) practices cardiology in the Odessa, TX market, with the plurality of this provider's patient population coming from Ector, TX. This provider's primary affiliated billing organization is MCH PROFESSIONAL CARE (NPI: 1649391269; TIN: 92-0192097) and primary practice location at 79761-5001. Boccalandro is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Boccalandro's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,016 traditional Medicare patients, billed 5,645 HCPCS/CPT codes, and received $223,030 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 10,255 prescription claims across 1,152 beneficiaries totaling $1,921,871 in drug costs, led by Eliquis (Apixaban). DME data shows 57 claims. Open Payments data shows 45 records totaling $754,549. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $366,764 to $223,030. In contrast, Part D prescription costs have moved from a lower plateau to a higher plateau, from $609,406 to $1,921,871. For DME billing, this smaller-volume category moved sharply higher in recent years, from $4,896 to $4,905.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,135	6,638	$366,764
2016	2,664	7,487	$365,463
2017	2,897	7,222	$319,537
2018	2,549	6,513	$292,096
2019	2,424	6,474	$303,972
2020	2,316	6,179	$262,872
2021	2,132	6,169	$297,156
2022	2,059	6,115	$273,519
2023	2,019	5,478	$236,822
2024	2,016	5,645	$223,030

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	937	7,418	$609,406
2016	1,043	8,462	$802,066
2017	1,130	9,448	$1,013,857
2018	1,135	9,698	$1,072,805
2019	1,151	10,448	$1,649,830
2020	1,160	10,595	$1,564,970
2021	1,144	9,629	$1,666,947
2022	1,224	10,245	$2,041,335
2023	1,191	9,903	$1,883,391
2024	1,152	10,255	$1,921,871

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	31	$3,099
2016	N/R	12	$886
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	24	$425
2022	N/R	N/R	N/R
2023	N/R	40	$2,862
2024	N/R	57	$4,905

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	410	581	$80
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	499	601	$53
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	416	434	$48
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	258	382	$10
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	1,097	1,883	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	779	37,636	$710,184
Entresto	Sacubitril/Valsartan	286	14,610	$320,388
Xarelto	Rivaroxaban	205	10,281	$184,043
Jardiance	Empagliflozin	194	9,292	$179,326
Opsumit	Macitentan	11	330	$136,878

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	33	$4,168
E1392	Portable oxygen concentrator, rental	Y	N/R	11	$436
E0431	Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing	Y	N/R	13	$300

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$578	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	18	$753,972	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fernando Boccalandro, M.D.?

Tedicare shows public-source Medicare data for Fernando Boccalandro, M.D. (NPI 1467441428), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fernando Boccalandro, M.D. have ACO affiliation data?

Fernando Boccalandro, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Fernando Boccalandro, M.D.?

Fernando Boccalandro, M.D. is linked to MCH PROFESSIONAL CARE (billing NPI 1649391269) in the available physician profile data.

Does Fernando Boccalandro, M.D. have Open Payments data?

Fernando Boccalandro, M.D. has 45 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.